05:28 PM EDT, 03/13/2024 (MT Newswires) -- Michael J. Labarre, Senior Vice President, Chief Technical Officer, on March 12, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $839,100. Following the Form 4 filing with the SEC, Labarre has control over a total of 156,558 shares of the company, with 156,558 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924007825/xslF345X03/form4-03132024_090313.xml